1. Home
  2. AMRX vs DEI Comparison

AMRX vs DEI Comparison

Compare AMRX & DEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • DEI
  • Stock Information
  • Founded
  • AMRX 2002
  • DEI 1971
  • Country
  • AMRX United States
  • DEI United States
  • Employees
  • AMRX N/A
  • DEI N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • DEI Real Estate Investment Trusts
  • Sector
  • AMRX Health Care
  • DEI Real Estate
  • Exchange
  • AMRX Nasdaq
  • DEI Nasdaq
  • Market Cap
  • AMRX 2.4B
  • DEI 2.8B
  • IPO Year
  • AMRX N/A
  • DEI 2006
  • Fundamental
  • Price
  • AMRX $8.19
  • DEI $16.15
  • Analyst Decision
  • AMRX Strong Buy
  • DEI Buy
  • Analyst Count
  • AMRX 5
  • DEI 9
  • Target Price
  • AMRX $10.80
  • DEI $18.50
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • DEI 2.5M
  • Earning Date
  • AMRX 05-02-2025
  • DEI 05-06-2025
  • Dividend Yield
  • AMRX N/A
  • DEI 4.69%
  • EPS Growth
  • AMRX N/A
  • DEI N/A
  • EPS
  • AMRX N/A
  • DEI 0.13
  • Revenue
  • AMRX $2,793,957,000.00
  • DEI $989,071,000.00
  • Revenue This Year
  • AMRX $10.49
  • DEI $0.22
  • Revenue Next Year
  • AMRX $7.00
  • DEI N/A
  • P/E Ratio
  • AMRX N/A
  • DEI $122.52
  • Revenue Growth
  • AMRX 16.73
  • DEI 0.46
  • 52 Week Low
  • AMRX $5.18
  • DEI $12.50
  • 52 Week High
  • AMRX $9.48
  • DEI $20.50
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.15
  • DEI 42.44
  • Support Level
  • AMRX $8.16
  • DEI $16.22
  • Resistance Level
  • AMRX $8.58
  • DEI $16.71
  • Average True Range (ATR)
  • AMRX 0.30
  • DEI 0.48
  • MACD
  • AMRX -0.07
  • DEI 0.02
  • Stochastic Oscillator
  • AMRX 23.40
  • DEI 38.52

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About DEI Douglas Emmett Inc.

Douglas Emmett Inc is a real estate investment trust that acquires, develops, and manages office and multifamily properties in Los Angeles, California and Honolulu, Hawaii in the U.S. The company focuses on owning assets in communities with large supply constraints, such as the affluent neighborhoods of Los Angeles. The vast majority of Douglas Emmett's real estate portfolio is comprised of office buildings in Los Angeles. Most of these assets are located in the areas of Sherman Oaks, Woodland Hills, and Beverly Hills in terms of total square feet. Douglas Emmett derives nearly all of its income in the form of rental revenue from tenants. The vast majority of this also comes from its Los Angeles office buildings. The company's major tenants are legal, financial, and entertainment firms.

Share on Social Networks: